Research in Næstved, Slagelse and Ringsted hospitals has been further strengthened when it comes to treatment of chronic conditions. With an EU grant of €1.5 million, the hospital can manifest and develop its work with patients who have more than one chronic condition in close collaboration with the University of Southern Denmark (SDU).
More than half of all patients with a chronic condition also have at least one other chronic condition and thus meet the definition of multi-morbidity. Compared to people with only one chronic condition, people with multi-morbidity are at higher risk of premature death, hospitalization as well as longer stay in hospital. At the same time, multi-morbidity is associated with poor functioning, low quality of life and depression as well as higher consumption of medicine and healthcare services.
In spite of this, existing research into effective treatment of multi-morbidity is limited, and the organization of the healthcare system for patients with multi-morbidity is ineffective and unsatisfactory for the patients.
The EU grant will fund a five-year project called MOBILIZE, which focuses on supervised, individualized training and education to enable multi-morbidity patients to better cope with their conditions. In this way, they can reduce the symptoms of their illnesses, increase their quality of life and prevent development of other chronic diseases.
The project is based on a strong interdisciplinary collaboration with the use of many different scientific methods and a high level of patient involvement throughout the research process to ensure that the project is relevant to patients and the healthcare system.
The funding is a Starting Grant from the European Research Council (ERC), which has been received by Søren Thorgaard Skou. Søren is associate professor at the Department of Sports Science and Clinical Biomechanics, Faculty of Health Sciences at the University of Southern Denmark (SDU), and physiotherapist responsible for research at the Department of Physiotherapy and Occupational Therapy at Næstved, Slagelse and Ringsted hospitals.